| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/26/2007 | WO2007082712A1 Long-acting colloidal formulation of insulin and preparation thereof |
| 07/26/2007 | WO2007082698A1 Foam-forming composition |
| 07/26/2007 | WO2007082548A1 Universal bi-cartridge |
| 07/26/2007 | WO2007082425A1 A chinese medicine composition and its process and use |
| 07/26/2007 | WO2007082416A1 Traditional chinese medical compositions for treating avian influenza, processes for preparation and usage thereof |
| 07/26/2007 | WO2007071325A3 Composition containing and active agent and polymeric carrier particles comprising a copolymer of a hydrophobic monomer and a hydrophilic polysaccharide |
| 07/26/2007 | WO2007058634B1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/26/2007 | WO2007052307A3 Stable solid oral dosage forms of valsartan |
| 07/26/2007 | WO2007052295A3 Aqueous anaesthetic compositions comprising propofol |
| 07/26/2007 | WO2007051743A3 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 07/26/2007 | WO2007049304A3 Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| 07/26/2007 | WO2007039569A3 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof |
| 07/26/2007 | WO2007038596A3 Phytosterol nutritional supplements |
| 07/26/2007 | WO2007029124A3 Formulations containing pantoprazole free acid and its salts |
| 07/26/2007 | WO2007025274A3 Self-assembling nanoparticles for the treatment of vascular diseases |
| 07/26/2007 | WO2007025142A3 Gel compositions comprising a combination of an antiseptic and an anesthetic agent for treating surface areas in medical and surgical procedures |
| 07/26/2007 | WO2007020507A3 Medicinal forms of phospholipid preparations and methods for their preparation |
| 07/26/2007 | WO2007006497A3 Solubilsation products of an active ingredient extract |
| 07/26/2007 | WO2006133954A3 Diclofenac formulations and methods of use |
| 07/26/2007 | WO2006133046A3 Nanoparticulate imatinib mesylate formulations |
| 07/26/2007 | WO2006123359A3 A process of making microspheres |
| 07/26/2007 | WO2006102728A3 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 07/26/2007 | WO2006055447A3 Nanoparticles having a magnetic core and a cationic organo-silane coating for the delivery of oligonucleotides |
| 07/26/2007 | US20070173905 Implantable retinal electrode array configuration for minimal retinal damage and method of reducing retinal stress |
| 07/26/2007 | US20070173787 Thin-film nitinol based drug eluting stent |
| 07/26/2007 | US20070173464 Oral ribavirin pharmaceutical compositions |
| 07/26/2007 | US20070173448 Solution for removing cataracts via liquefracture |
| 07/26/2007 | US20070173446 Administering porcine B-domainless factor VIII (OBI-1) to patient having factor VIII deficiency using recombinant B-domainless porcine fVIII, which has greater bioavailability compared to the natural porcine fVIII partially purified from porcine plasma, termed HYATE:C; hemophilia treatment |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172950 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use of gene transfer |
| 07/26/2007 | US20070172526 Radiopaque fibers and filtration matrices |
| 07/26/2007 | US20070172525 Anti-diabetic combinations |
| 07/26/2007 | US20070172524 Process for preparing a solid pharmaceutical composition |
| 07/26/2007 | US20070172523 Soft-gelatin capsule formulation |
| 07/26/2007 | US20070172522 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 07/26/2007 | US20070172521 Levetiracetam formulations and methods for their manufacture |
| 07/26/2007 | US20070172520 Immunotargeting of Nonionic Surfactant Vesicles |
| 07/26/2007 | US20070172518 Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172515 Film bandage for mucosal administration of actives |
| 07/26/2007 | US20070172513 Encapsulation of oxygen sensitive agents |
| 07/26/2007 | US20070172511 Food Products Comprising a Slowly Digestible or Digestion Resistant Carbohydrate Composition |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172475 Highly concentrated, liquid formulations of anti-egfr antibodies |
| 07/26/2007 | US20070172459 modified interferons for use in the treatment and prevention of viral infections, cell proliferative and autoimmune disorders |
| 07/26/2007 | US20070172432 Biodegradable hemostatic compositions |
| 07/26/2007 | US20070172430 Dry powder compositions for rna influenza therapeutics |
| 07/26/2007 | US20070172429 Labeling compositions and methods of use for deterrent trackability |
| 07/26/2007 | DE102006026060A1 Transdermales Therapeutisches System für flüchtige und/oder thermolabile Stoffe Transdermal therapeutic system for volatile and / or thermolabile substances |
| 07/26/2007 | CA2639921A1 Microspheres comprising nanocapsules containing a lipophilic drug |
| 07/26/2007 | CA2638034A1 A lyophilized solid taxane composition, a process for preparing said solid composition, a pharmaceutical formulation and a kit of said formulation |
| 07/26/2007 | CA2637893A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| 07/26/2007 | CA2637755A1 Dosage form and method for the delivery of drugs of abuse |
| 07/26/2007 | CA2637655A1 Method and apparatus for forming delivery devices for oral intake of an agent |
| 07/26/2007 | CA2637635A1 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 07/26/2007 | CA2637564A1 Thimerosal removal device |
| 07/26/2007 | CA2637444A1 Coated pharmaceutical composition of tolterodine or a salt thereof having rapid dissolution at acidic conditions and slow dissolution at higher ph values |
| 07/26/2007 | CA2637408A1 Foam-forming composition |
| 07/26/2007 | CA2637359A1 Central administration of stable formulations of therapeutic agents for cns conditions |
| 07/26/2007 | CA2637240A1 Pharmaceutical valatograst compositions and process for manufacturing same |
| 07/26/2007 | CA2637074A1 Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers |
| 07/26/2007 | CA2637065A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances |
| 07/26/2007 | CA2636716A1 Microparticle containing matrices for drug delivery |
| 07/26/2007 | CA2636582A1 Film bandage for mucosal administration of actives |
| 07/26/2007 | CA2636339A1 Biologically active composition comprising ethylcellulose |
| 07/26/2007 | CA2636173A1 Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
| 07/26/2007 | CA2636026A1 Film lined pouch and method of manufacturing this pouch |
| 07/26/2007 | CA2635251A1 Stable therapeutic formulations |
| 07/25/2007 | EP1811036A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/25/2007 | EP1810743A1 Process for producing microsphere with use of metal substrate having through-hole |
| 07/25/2007 | EP1810695A1 Non-aqueous liquid shampoo composition |
| 07/25/2007 | EP1810694A2 Water-soluble compositions of bioactive lipophilic compounds |
| 07/25/2007 | EP1810688A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 07/25/2007 | EP1810684A2 Anticancer agent |
| 07/25/2007 | EP1810679A2 Controlled release oxycodone compositions |
| 07/25/2007 | EP1810669A1 Application form for burprenorphine |
| 07/25/2007 | EP1810668A1 Coated formulations containing tolterodine tartrate |
| 07/25/2007 | EP1810667A1 Pharmaceutical composition comprising amorphous atorvastatin |
| 07/25/2007 | EP1810666A1 Foam-Forming composition |
| 07/25/2007 | EP1810665A1 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 07/25/2007 | EP1809329A2 Sustained local anesthetic composition containing prefrably a sugar ester such as saib |
| 07/25/2007 | EP1809310A2 Bioactive wound dressings and implantable devices and methods of use |
| 07/25/2007 | EP1809307A1 Medical solution, method for producing and use thereof |
| 07/25/2007 | EP1809305A2 Phosphate binder with reduced pill burden |
| 07/25/2007 | EP1809295A2 Novel formulations of eprosartan with enhanced bioavailability |
| 07/25/2007 | EP1809291A1 Pharmaceutical compositions for transdermal delivery |
| 07/25/2007 | EP1809279A1 Nanoparticulate compositions of tubulin inhibitor |
| 07/25/2007 | EP1809274A2 Pharmaceutical composition for rectal or vaginal application comprising a platinum complex |
| 07/25/2007 | EP1809269A1 Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection |
| 07/25/2007 | EP1809264A2 Antimicrobial amorphous compositions |
| 07/25/2007 | EP1809263A1 New modif ied release peelet formulat ions for proton pump inhibitors |
| 07/25/2007 | EP1809262A1 New modified release tablet formulations for proton pump inhibitors |
| 07/25/2007 | EP1809261A1 Non-gelatin soft capsule system |
| 07/25/2007 | EP1809260A1 Aqueous pharmaceutical coating |
| 07/25/2007 | EP1809259A2 Less abusable pharmaceutical preparations |
| 07/25/2007 | EP1809258A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 07/25/2007 | EP1809257A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 07/25/2007 | EP1809256A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 07/25/2007 | EP1809255A1 High-dosage extended-release formulation of gepirone |
| 07/25/2007 | EP1809254A2 Lyophilized liposome formulations and method |